How to Get Jakafi (Ruxolitinib) Covered by Blue Cross Blue Shield in Pennsylvania: Complete Guide to Prior Authorization and Appeals
Answer Box: Jakafi (ruxolitinib) requires prior authorization from all Blue Cross Blue Shield plans in Pennsylvania. Your doctor must document your diagnosis (myelofibrosis or polycythemia vera), prove hydroxyurea failure or intolerance, and submit clinical notes through your plan's PA portal. If denied, Pennsylvania's new external review